Will Stone
Will Stone is a former reporter at KUNR Public Radio.
-
For a year, researchers have been studying and arguing over vitamin D's potential for helping protect against or treat COVID-19. The evidence is still not conclusive. -
Pausing use of the Johnson and Johnson vaccine looks unlikely to cause major problems in the overall U.S. vaccination effort, but some places counting on those doses are scrambling.
-
Researchers have quantified the price paid for fast-spreading COVID-19 infections. Patients who might have survived otherwise perished in crowded ICUs. -
The Aldaco family of Phoenix suffered more than most in this year of unfathomable losses. Three brothers perished in the pandemic: Jose in July, Heriberto in December and Gonzalo in February. -
As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over. -
The country has beat back the winter surge, and experts credit Americans' improved compliance with precautions like mask-wearing. But we could we still face a resurgence if we let up. -
Glitchy websites, jammed phone lines and long lines outside clinics are complicating the vaccine rollout. And older Americans and those without caregivers and computer skills are at a disadvantage. -
COVID-19 has now killed more Americans than WWII. That fact helps some people put the viral death toll in perspective, while others find it offensive. Historically, is it even a valid comparison? -
Large corporations such as Starbucks, Honeywell, Microsoft, Costco and Google want to help states with planning and logistics. But the potential of these partnerships is hindered by supply problems. -
Although vaccination has begun, this winter has been the deadliest season of the pandemic. The U.S. death toll jumped from 300,000 to 400,000 in just five weeks.
